2025 ICD-10-PCS Procedure Code XW043Q5

by

Introduction of Tagraxofusp-erzs Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5

  • ICD-10-PCS XW043Q5 is a specific/billable code that can be used to indicate a procedure.

Code History

  • 2020 (effective 10/1/2019): New code
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change
  • 2025 (effective 10/1/2024): No change